Wilmington, United States
SPI Pharma is a company dedicated to solving formulation challenges through the use of superior functional materials. With a history spanning over 75 years, they have been supplying the pharmaceutical industry with highly engineered products and innovative solutions that aim to improve the formulation and delivery of drug products to meet patient needs. Their functional excipients and active ingredients adhere to the highest-quality standards and offer customized, cost-effective options for a wide range of applications. The company is headquartered in the United States and operates within the Biotechnology, Health Care, and Pharmaceutical industries.
Since the company's founding in 1964, it has established itself as a key player in the pharmaceutical supply chain. With an overarching focus on product innovation and quality, SPI Pharma caters to the evolving needs of the industry. The company's slogan reflects its commitment to addressing the complexities of drug formulation while leveraging advanced materials.
Despite the absence of publicly available information on the latest investment and the involved investors, SPI Pharma's longstanding presence in the pharmaceutical sector, coupled with its focus on innovative solutions, positions it as a potential candidate for strategic investments from venture capital firms seeking to participate in the advancement of drug formulation and delivery technologies.
KABS Laboratories Inc.
